WOLFRAM EISENREICH,THOMAS FRIEDL,FLORIAN SOMMER,NANTHARAT PEARNCHOB,KARL GERHARD WAGNER
申请号：
BRPI0716439
公开号：
BRPI0716439A2
申请日:
2007.08.10
申请国别(地区):
BR
年份:
2013
代理人:
摘要：
The present invention provides pharmaceutical release systems comprising an therapeutically effective amount of flibanserin and at least one pharmaceutically acceptable excipient, characterized in that said pharmaceutical release systems exhibit a pharmacokinetic profile that is characterized by an average maximum flibanserin plasma concentration Cmax lower than 300 ng/mL, preferably lower than 200 ng/mL after administration of a single dose to healthy volunteers in fasted state or directly after a meal.
